Cargando…
A self-assembled leucine polymer sensitizes leukemic stem cells to chemotherapy by inhibiting autophagy in acute myeloid leukemia
Chemotherapy is the primary treatment option for acute myeloid leukemia (AML), but leukemic stem cells (LSC) can survive chemotherapy for disease recurrence and refractory. Here, we found that AML cells obtained from relapsed patients had increased autophagy levels than de novo AML cells. Furthermor...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521229/ https://www.ncbi.nlm.nih.gov/pubmed/35295079 http://dx.doi.org/10.3324/haematol.2021.280290 |
_version_ | 1784799796698021888 |
---|---|
author | Xu, Xi Wang, Jian Tong, Tong Zhang, Wenwen Wang, Jin Ma, Weiwei Wang, Shunqing Zhou, Dunhua Wu, Jun Jiang, Linjia Zhao, Meng |
author_facet | Xu, Xi Wang, Jian Tong, Tong Zhang, Wenwen Wang, Jin Ma, Weiwei Wang, Shunqing Zhou, Dunhua Wu, Jun Jiang, Linjia Zhao, Meng |
author_sort | Xu, Xi |
collection | PubMed |
description | Chemotherapy is the primary treatment option for acute myeloid leukemia (AML), but leukemic stem cells (LSC) can survive chemotherapy for disease recurrence and refractory. Here, we found that AML cells obtained from relapsed patients had increased autophagy levels than de novo AML cells. Furthermore, doxorubicin (DOX) treatment stimulated autophagy in LSC by repressing the mTOR pathway, and pharmaceutical inhibition of autophagy rendered chemoresistant LSC sensitive to DOX treatment in MLL-AF9 induced murine AML. Moreover, we developed a self-assembled leucine polymer, which activated mTOR to inhibit autophagy in AML cells by releasing leucine. The leucine polymer loaded DOX (Leu-DOX) induced much less autophagy but more robust apoptosis in AML cells than the DOX treatment. Notably, the leucine polymer and Leu-DOX were specifically taken up by AML cells and LSC but not by normal hematopoietic cells and hematopoietic stem/progenitor cells in the bone marrow. Consequently, Leu-DOX efficiently reduced LSC and prolonged the survival of AML mice, with more limited myeloablation and tissue damage side effects than DOX treatment. Overall, we proposed that the newly developed Leu-DOX is an effective autophagy inhibitor and an ideal drug to efficiently eliminate LSC, thus serving as a revolutionary strategy to enhance the chemotherapy efficacy in AML. |
format | Online Article Text |
id | pubmed-9521229 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Fondazione Ferrata Storti |
record_format | MEDLINE/PubMed |
spelling | pubmed-95212292022-10-24 A self-assembled leucine polymer sensitizes leukemic stem cells to chemotherapy by inhibiting autophagy in acute myeloid leukemia Xu, Xi Wang, Jian Tong, Tong Zhang, Wenwen Wang, Jin Ma, Weiwei Wang, Shunqing Zhou, Dunhua Wu, Jun Jiang, Linjia Zhao, Meng Haematologica Article - Acute Myeloid Leukemia Chemotherapy is the primary treatment option for acute myeloid leukemia (AML), but leukemic stem cells (LSC) can survive chemotherapy for disease recurrence and refractory. Here, we found that AML cells obtained from relapsed patients had increased autophagy levels than de novo AML cells. Furthermore, doxorubicin (DOX) treatment stimulated autophagy in LSC by repressing the mTOR pathway, and pharmaceutical inhibition of autophagy rendered chemoresistant LSC sensitive to DOX treatment in MLL-AF9 induced murine AML. Moreover, we developed a self-assembled leucine polymer, which activated mTOR to inhibit autophagy in AML cells by releasing leucine. The leucine polymer loaded DOX (Leu-DOX) induced much less autophagy but more robust apoptosis in AML cells than the DOX treatment. Notably, the leucine polymer and Leu-DOX were specifically taken up by AML cells and LSC but not by normal hematopoietic cells and hematopoietic stem/progenitor cells in the bone marrow. Consequently, Leu-DOX efficiently reduced LSC and prolonged the survival of AML mice, with more limited myeloablation and tissue damage side effects than DOX treatment. Overall, we proposed that the newly developed Leu-DOX is an effective autophagy inhibitor and an ideal drug to efficiently eliminate LSC, thus serving as a revolutionary strategy to enhance the chemotherapy efficacy in AML. Fondazione Ferrata Storti 2022-03-17 /pmc/articles/PMC9521229/ /pubmed/35295079 http://dx.doi.org/10.3324/haematol.2021.280290 Text en Copyright© 2022 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
spellingShingle | Article - Acute Myeloid Leukemia Xu, Xi Wang, Jian Tong, Tong Zhang, Wenwen Wang, Jin Ma, Weiwei Wang, Shunqing Zhou, Dunhua Wu, Jun Jiang, Linjia Zhao, Meng A self-assembled leucine polymer sensitizes leukemic stem cells to chemotherapy by inhibiting autophagy in acute myeloid leukemia |
title | A self-assembled leucine polymer sensitizes leukemic stem cells to chemotherapy by inhibiting autophagy in acute myeloid leukemia |
title_full | A self-assembled leucine polymer sensitizes leukemic stem cells to chemotherapy by inhibiting autophagy in acute myeloid leukemia |
title_fullStr | A self-assembled leucine polymer sensitizes leukemic stem cells to chemotherapy by inhibiting autophagy in acute myeloid leukemia |
title_full_unstemmed | A self-assembled leucine polymer sensitizes leukemic stem cells to chemotherapy by inhibiting autophagy in acute myeloid leukemia |
title_short | A self-assembled leucine polymer sensitizes leukemic stem cells to chemotherapy by inhibiting autophagy in acute myeloid leukemia |
title_sort | self-assembled leucine polymer sensitizes leukemic stem cells to chemotherapy by inhibiting autophagy in acute myeloid leukemia |
topic | Article - Acute Myeloid Leukemia |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521229/ https://www.ncbi.nlm.nih.gov/pubmed/35295079 http://dx.doi.org/10.3324/haematol.2021.280290 |
work_keys_str_mv | AT xuxi aselfassembledleucinepolymersensitizesleukemicstemcellstochemotherapybyinhibitingautophagyinacutemyeloidleukemia AT wangjian aselfassembledleucinepolymersensitizesleukemicstemcellstochemotherapybyinhibitingautophagyinacutemyeloidleukemia AT tongtong aselfassembledleucinepolymersensitizesleukemicstemcellstochemotherapybyinhibitingautophagyinacutemyeloidleukemia AT zhangwenwen aselfassembledleucinepolymersensitizesleukemicstemcellstochemotherapybyinhibitingautophagyinacutemyeloidleukemia AT wangjin aselfassembledleucinepolymersensitizesleukemicstemcellstochemotherapybyinhibitingautophagyinacutemyeloidleukemia AT maweiwei aselfassembledleucinepolymersensitizesleukemicstemcellstochemotherapybyinhibitingautophagyinacutemyeloidleukemia AT wangshunqing aselfassembledleucinepolymersensitizesleukemicstemcellstochemotherapybyinhibitingautophagyinacutemyeloidleukemia AT zhoudunhua aselfassembledleucinepolymersensitizesleukemicstemcellstochemotherapybyinhibitingautophagyinacutemyeloidleukemia AT wujun aselfassembledleucinepolymersensitizesleukemicstemcellstochemotherapybyinhibitingautophagyinacutemyeloidleukemia AT jianglinjia aselfassembledleucinepolymersensitizesleukemicstemcellstochemotherapybyinhibitingautophagyinacutemyeloidleukemia AT zhaomeng aselfassembledleucinepolymersensitizesleukemicstemcellstochemotherapybyinhibitingautophagyinacutemyeloidleukemia AT xuxi selfassembledleucinepolymersensitizesleukemicstemcellstochemotherapybyinhibitingautophagyinacutemyeloidleukemia AT wangjian selfassembledleucinepolymersensitizesleukemicstemcellstochemotherapybyinhibitingautophagyinacutemyeloidleukemia AT tongtong selfassembledleucinepolymersensitizesleukemicstemcellstochemotherapybyinhibitingautophagyinacutemyeloidleukemia AT zhangwenwen selfassembledleucinepolymersensitizesleukemicstemcellstochemotherapybyinhibitingautophagyinacutemyeloidleukemia AT wangjin selfassembledleucinepolymersensitizesleukemicstemcellstochemotherapybyinhibitingautophagyinacutemyeloidleukemia AT maweiwei selfassembledleucinepolymersensitizesleukemicstemcellstochemotherapybyinhibitingautophagyinacutemyeloidleukemia AT wangshunqing selfassembledleucinepolymersensitizesleukemicstemcellstochemotherapybyinhibitingautophagyinacutemyeloidleukemia AT zhoudunhua selfassembledleucinepolymersensitizesleukemicstemcellstochemotherapybyinhibitingautophagyinacutemyeloidleukemia AT wujun selfassembledleucinepolymersensitizesleukemicstemcellstochemotherapybyinhibitingautophagyinacutemyeloidleukemia AT jianglinjia selfassembledleucinepolymersensitizesleukemicstemcellstochemotherapybyinhibitingautophagyinacutemyeloidleukemia AT zhaomeng selfassembledleucinepolymersensitizesleukemicstemcellstochemotherapybyinhibitingautophagyinacutemyeloidleukemia |